Cargando…
Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
BACKGROUND: Numerous clinical trials have reported conflicting results regarding the benefit of digoxin in treating heart failure (HF) patients. This study was conducted with the aim to demonstrate the impact of added digoxin to beta-blocker and beta-blocker alone on all-cause mortality and rehospit...
Autores principales: | Yazdi, Maryam, Shafie, Davood, Givi, Mahshid, Garakyaraghi, Mohammad, Sarrafzadegan, Nizal, Yadegarfar, Ghasem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931945/ https://www.ncbi.nlm.nih.gov/pubmed/36815953 http://dx.doi.org/10.48305/arya.v18i0.2329 |
Ejemplares similares
-
Design and methodology of heart failure registry: Results of the Persian registry of cardiovascular disease
por: Givi, Mahshid, et al.
Publicado: (2019) -
Patients Characteristics and Preliminary Outcomes of Heart Failure Registry in A Middle-Income Country: Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF)
por: Givi, Mahshid, et al.
Publicado: (2018) -
The association between particulate matter 2.5 and hospitalization and mortality rates of heart failure: The CAPACITY study
por: Moein, Nafise, et al.
Publicado: (2019) -
Persian Registry Of cardioVascular diseasE (PROVE): Design and methodology
por: Givi, Mahshid, et al.
Publicado: (2017) -
Relation between Hemoconcentration Status and Readmission Plus Mortality Rate Among Iranian Individuals with Decompensated Heart Failure
por: Yadollahi Farsani, Ashkan, et al.
Publicado: (2020)